|
|
|
|
Arthritis drugs U-turn a help for sufferers
HUNDREDS of lives in Burton will be improved by a U-turn on rationing arthritis drugs, a support worker and sufferer believes.Rationing watchdog Nice yesterday overturned its decision to restrict access to 100-a-week anti-TNFs,...
|
|
|
Intramembranous microspherical structures in focal segmental glomerulosclerosis
Inoue Y et al.- A 45-year-old male had proteinuria for 3 years. For persistent proteinuria over 2 g/day, he underwent renal biopsy. Light microscopy revealed focal segmental glomerulosclerosis together with diffuse capillary wall...
|
|
|
Antecedent Nonbladder Syndromes in Case-Control Study of Interstitial Cystitis/Painful Bladder Syndr
Objectives: Probing for clues to the pathogenesis of interstitial cystitis/painful bladder syndrome (IC/PBS), we sought antecedent nonbladder syndromes that distinguished incident IC/PBS cases from matched controls.Methods: Female...
|
|
|
November 12, 2008
Objectives: Probing for clues to the pathogenesis of interstitial cystitis/painful bladder syndrome (IC/PBS), we sought antecedent nonbladder syndromes that distinguished incident IC/PBS cases from matched controls.Methods: Female...
|
|
|
Parion and Kainos sign development agreement
DURHAM, N.C.- and Korean pharma Kainos Medicines Inc.recently announced they reached an agreement to co-develop Parion's proprietary epithelial sodium channel blocker, P-552, for the treatment of dry mouth associated with primary ...
|
|
|
Rheumatoid arthritis and dry eye
Role of severity of arthritis and medications explored in dry eye study 30 year old female, suffering from rheumatoid arthritis, has bilateral multiple filamentary keratitis and dry eye.The life long management of these cases is most...
|
|
|
TorreyPines Therapeutics Reports Third Quarter 2008 Results and Recent Accomplishments
/PRNewswire/ -- TorreyPines Therapeutics, Inc.today announced financial results for the third quarter ended September 30, 2008. For the three-month period, the Company posted revenue of $1.2 million and a net loss of $5.4 million.
|
|
|
Mucosa-Associated Lymphoid Tissue Lymphoma in Sjogren's Syndrome: Risks, Management, and Prognosis
_ Mucosa-Associated Lymphoid Tissue Lymphoma in Sjogren's Syndrome: Risks, Management, and Prognosis.
|
|
|
Patient-Reported Outcomes Including Fatigue in Primary Sjogren's Syndrome
Bowman SJ et al.- Article reviews these patient-reported features, their relationships with objective assessment of the disease, potential therapies for these symptoms, and how measurements of these symptoms are relevant to outcome...
|
|
|
TorreyPines Therapeutics Reports Third Quarter 2008 Results and Recent Accomplishments
LA JOLLA, Calif., Nov.12 /PRNewswire/ -- TorreyPines Therapeutics, Inc. today announced financial results for the third quarter ended September 30, 2008. For the three-month period, the Company posted revenue of $1.2 million and a net...
|
|
|
TorreyPines Therapeutics Reports Third Quarter 2008 Results and Recent Accomplishments
LA JOLLA, Calif., Nov.12 /PRNewswire/ -- TorreyPines Therapeutics, Inc. today announced financial results for the third quarter ended September 30, 2008. For the three-month period, the Company posted revenue of $1.2 million and a net...
|
|
|
TorreyPines Therapeutics Reports Third Quarter 2008 Results and Recent Accomplishments
LA JOLLA, Calif., Nov.12 /PRNewswire/ -- TorreyPines Therapeutics, Inc. today announced financial results for the third quarter ended September 30, 2008. For the three-month period, the Company posted revenue of $1.2 million and a net...
|
|
|
Marillion Pharmaceuticals and Bracco Imaging S.p.A. Announce License Agreement to Develop and Commercialize No
MALVERN, Pa.& PRINCETON, N.J.--(BUSINESS WIRE)--Nov. 11, 2008 - Marillion Pharmaceuticals Inc. and Bracco Imaging S.p.A., one of the world's leading companies in the diagnostic imaging business and part of the Bracco Group,...
|
|
|
Dry Eye Survey: Ophthalmologists Cite Treatment Limitations/Gaps in Treatment of Moderate to Severe Dry Eye
LAWRENCEVILLE, N.J., Nov.10 /PRNewswire/ -- Aton Pharma, Inc., a diversified specialty pharmaceutical company, announced results of a recent survey of ophthalmologists regarding issues in the treatment of moderate to severe cases of dry...
|
|
|
Dry Eye Survey: Ophthalmologists Cite Treatment Limitations/Gaps in Treatment of Moderate to Severe Dry Eye
LAWRENCEVILLE, N.J., Nov.10 /PRNewswire/ -- Aton Pharma, Inc., a diversified specialty pharmaceutical company, announced results of a recent survey of ophthalmologists regarding issues in the treatment of moderate to severe cases of dry...
|
|
|
TorreyPines Divests Alzheimer's Discovery Program to Eisai
TorreyPines Therapeutics is selling its Alzheimer's disease genetics research program to Eisai after collaborating since 2002.The program is focused on the discovery of Alzheimer's targets using whole-genome family-based association...
|
|
|
Dry eyes, mouth signs of Sjogren's
Posted By Dr.Paul G. Donohue Dear Dr. Donohue: I would like to know more about Sjogren's syndrome. The doctor made the diagnosis after taking more than 25 blood tests. He is a rheumatologist. I am afraid I will get cancer...
|
|
|
Anti-CD20 treatment in Primary Sjogren's Syndrome
Seminars in Thrombosis and Hemostasis, 08/22/08 Seminars in Thrombosis and Hemostasis, 08/22/08 Autoimmunity Reviews, 10/14/08 Anti-CD20 treatment in Primary Sjogren's Syndrome.
|
|
|
Rituximab May Ease Fatigue in Sjogren's Syndrome
_ Rituximab May Ease Fatigue in Sjogren's Syndrome.
|
|
|
Treating Systemic Lupus Erythematosus
Erosive oral lesions and desquamative gingivitis are 2 observable manifestations of Systemic Lupus Erythematosus (SLE), and they are only some of the many symptoms patients may exhibit.SLE is a chronic rheumatic autoimmune disease...
|
|
|
Dry eyes, mouth signs of Sjogren's syndrome
DEAR DR.DONOHUE: I would like to know more about Sjogren's syndrome. The doctor made the diagnosis after taking more than 25 blood tests. He is a rheumatologist. I am afraid I will get cancer because of it. The doctor has...
|
|
|
Dry eyes, mouth point to Sjogren's syndrome
DEAR DR.DONOHUE: I would like to know more about Sjogren's syndrome. The doctor made the diagnosis after taking more than 25 blood tests. He is a rheumatologist. I am afraid I will get cancer because of it. The doctor has...
|
|
|
Dr. Paul Donohue: Dry eyes and mouth point to Sjogren's syndrome
Dear Dr.Donohue: I would like to know more about Sjogren's syndrome. The doctor made the diagnosis after taking more than 25 blood tests. He is a rheumatologist. I am afraid I will get cancer because of it. The doctor has...
|
|
|
Dry eyes and mouth point to Sjogren's syndrome
Dear Dr.Donohue: I would like to know more about Sjogren's syndrome. The doctor made the diagnosis after taking more than 25 blood tests. He is a rheumatologist. I am afraid I will get cancer because of it. The doctor has...
|
|
|
Green tea compound may prevent diabetes: study
-0400 (Reuters Health) NEW YORK (Reuters Health) - A compound found in green tea could slow or even prevent the development of type 1 diabetes, new research in mice suggests.Green tea contains several antioxidants that have been shown to...
|
